Effects of mobile phone application combined with or without self-monitoring of blood glucose on glycemic control in patients with diabetes: A randomized controlled trial

Journal of Diabetes Investigation
Yuan YuBo Feng

Abstract

There is potential for mobile applications to deliver new self-management interventions for chronic disease, especially in diabetes. The aim of the present study was to evaluate the effects of a mobile phone application (MPA) combined with or without self-monitoring of blood glucose (SMBG) on glycemic control in patients with diabetes. The study was a 24-week period, four-arm parallel group, non-blinded, randomized trial. A total of 185 patients with mean age of 52 years were randomized to group A (no MPA and no SMBG), group B (SMBG only), group C (MPA only) and group D (both MPA and SMBG were used). Changes in glycated hemoglobin (HbA1c), fasting plasma glucose and 1,5-anhydroglucitol from baseline to week 24 were analyzed. At 24 weeks, the HbA1c levels in patients of all groups decreased significantly from baseline. There were significant differences in the proportions of patients that achieved HbA1c <7% between groups, especially in group C and group D, compared with group A at week 24 (60.4%, 62.2% vs 25.5%, all P < 0.05). 1,5-Anhydroglucitol changes were obvious in group A and group C at week 24 from baseline (all P < 0.05 within groups). Factorial analysis of anova showed that MPA intervention was the main effective facto...Continue Reading

References

Feb 27, 2013·Journal of Diabetes Science and Technology·Omar El-GayarWael Eid
Sep 5, 2013·JAMA : the Journal of the American Medical Association·Yu XuUNKNOWN 2010 China Noncommunicable Disease Surveillance Group
Nov 15, 2013·Journal of Medical Internet Research·Morwenna KirwanMitch J Duncan
Feb 8, 2014·Diabetes Technology & Therapeutics·Nazar S HaddadJohn W Gregory
Mar 19, 2014·Diabetes Research and Clinical Practice·L GuariguataJ E Shaw
May 31, 2014·Journal of Diabetes Science and Technology·Charlene C QuinnAnn L Gruber-Baldini
Feb 19, 2015·Diabetes Technology & Therapeutics·Charlene C QuinnAnn L Gruber-Baldini
Apr 15, 2015·Clinical Therapeutics·Bonnie KatalenichVivian Fonseca
May 2, 2017·Indian Journal of Endocrinology and Metabolism·Shruti MuralidharanViswanathan Mohan
Jun 28, 2017·JAMA : the Journal of the American Medical Association·Limin WangLinhong Wang
Dec 15, 2017·Therapeutic Advances in Endocrinology and Metabolism·Baris SaglamBanu Onvural
Jul 19, 2018·Clinica Chimica Acta; International Journal of Clinical Chemistry·Marciane WelterGeraldo Picheth
Sep 29, 2018·Journal of Diabetes Science and Technology·Kasun C GunawardenaDimuthu Muthukuda

❮ Previous
Next ❯

Citations

Feb 16, 2021·JMIR MHealth and UHealth·Claudia EberleStefanie Stichling
May 14, 2021·Current Atherosclerosis Reports·Maan Isabella CajitaLora E Burke

❮ Previous
Next ❯

Software Mentioned

Stata
WellDoc
Diabetes
‐ Carer
SPSS

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.